Yifan Pharmaceutical Co Ltd - Company Profile
Powered by 
All the data and insights you need on Yifan Pharmaceutical Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Yifan Pharmaceutical Co Ltd Strategy Report
- Understand Yifan Pharmaceutical Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Yifan Pharmaceutical Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
| Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
|---|---|---|---|---|
| 02 Jun 2022 | Yifan Pharma and Sino Biopharma Invest USD70 Million in Yiyi Biopharma | Equity Offering |
Sino Biopharmaceutical Ltd
Yifan Pharmaceutical Co Ltd |
Yiyi Biopharmaceutical (Beijing) Co Ltd
|
| 31 Dec 2020 | ITabMed (Tianweiyuan and Biomedicine) Spins out from Generon BioMed | Equity Offering | - |
ITabMed Co Ltd
|
| 27 Sep 2018 | Amyris Enters into Collaboration Agreement with Yifan Pharmaceutical | Partnership | - |
Amyris Inc Yifan Pharmaceutical Co Ltd |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
| 06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer